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Abstract
Background: Cross-species primers have been used with moderate success to address a variety
of questions concerning genome structure, evolution, and gene function. However, the factors
affecting their success have never been adequately addressed, particularly with respect to
producing a consistent method to achieve high throughput. Using 1,147 mammalian cross-species
primer pairs (1089 not previously reported), we tested several factors to determine their influence
on the probability that a given target will amplify in a given species under a single amplification
condition. These factors included: number of mismatches between the two species (the index
species) used to identify conserved regions to which the primers were designed, GC-content of
the gene and amplified region, CpG dinucleotides in the primer region, degree of encoded protein
conservation, length of the primers, and the degree of evolutionary distance between the target
species and the two index species.
Results: The amplification success rate for the cross-species primers was significantly influenced
by the number of mismatches between the two index species (6–8% decrease per mismatch in a
primer pair), the GC-content within the amplified region (for the dog, GC ≥ 50%, 56.9% amplified;
GC<50%, 74.2% amplified), the degree of protein conservation (R2 = 0.14) and the relatedness of
the target species to the index species. For the dog, 598 products of 930 primer pairs (64.3%)
(excluding primers in which dog was an index species) were sequenced and shown to be the
expected product, with an additional three percent producing the incorrect sequence. When
hamster DNA was used with the single amplification condition in a microtiter plate-based format,
510 of 1087 primer pairs (46.9%) produced amplified products. The primer pairs are spaced at an
average distance of 2.3 Mb in the human genome and may be used to produce up to several
hundred thousand bp of species-specific sequence.
Conclusion: The most important factors influencing the proportion of successful amplifications
are the number of index species mismatches, GC-richness of the target amplimer, and the
relatedness of the target species to the index species, at least under the single PCR condition used.
The 1147 cross-species primer pairs can be used in a high throughput manner to generate data for
studies on the genetics and genomics of non-sequenced mammalian genomes.
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Background
Cross-species polymerase chain reaction (PCR) primers
are often used to amplify part of a gene or genome for
which no direct species-specific sequence information is
available. There are a number of uses for these primers
including the development of genetic maps for linkage
analysis, identification of genetic markers for use in con-
servation biology, development of RH maps in studies of
chromosomal evolution, and sequence comparisons for
studies of molecular evolution for species whose genome
sequences have not yet been determined [1-5]. The sim-
plest method of producing cross-species primers is to
design primers to a region of a genome for a given species
and then to empirically test these for amplification in
other species. For example, primer pairs designed to flank
avian microsatellite repeats in one species have been used
to amplify homologous sequences in other closely related
avian species [6]. A limitation of this method is that it is
not possible to predict the likelihood that any given
primer set will work in another species because the evolu-
tionary history of the primer binding region across species
is unknown. However, such primer sets have been shown
to be useful for the amplification of the homologous tar-
get in relatively closely related species [7]. Not surpris-
ingly, there is a strong correlation between the proportion
of sets that work in other species and the genetic distance
of those species from the species for which the primers
where designed in the first place. It has been estimated
that 50% of these primer sets will work for avian species
that have diverged by 11 MY (millions of years) for passer-
ines and 23 MY for non-passerines [7].
It is known, in a general sense, that the more mismatches
there are between a primer and a target, the less likely the
target is to PCR-amplify. A way to reduce the probability
of mismatches between primers and targets is to pick
regions of the genome that are more conserved than those
picked more or less at random. Coding regions of genes
are known to be more conserved than intronic or inter-
genic regions. An early variation of this approach was to
use a computer program to design primers in coding
regions of genes judged to be optimal for amplification in
one species, and then test these primers in other species
[8]. Although the program would often pick identical or
nearly identical regions between primates and rodents,
the choice of regions conserved between species did not
appear to be a primary design consideration. Another
approach is to design degenerate primers to conserved
coding regions. However, it is generally acknowledged
that degenerate primers often result in amplification of
not only the desired target but also of artifactual bands
and non-orthologous homologues (indeed, amplification
of multiple family members is often the point of this pow-
erful technique; [9]). However, if the goal is to amplify a
single target gene in a family, say for the purpose of build-
ing a genetic map, great care is needed to identify the
desired product among multiple bands in contrast to
unique-sequence primers that often produce only a single
band.
Use of conservation of sequence as a design consideration
for unique sequence cross-species primers has been used
by many laboratories for small numbers of cross-species
primers used for specific targets (e.g., [10,11]). However,
at least three larger panels of cross-species primers have
been developed for more general use in mammals [12-
14]. The primer pairs in these panels often require some
degree of reaction optimization that has hindered their
wider use. In order to increase the efficiency with which
cross-species primer panels can be used, we have devel-
oped a new panel of mammalian cross-species primers
which can be used to examine the influence of various
design parameters, and for which a reasonably predictable
proportion will work for any given mammalian species
under a single PCR condition. Although it is thought that
inexpensive whole genome sequencing, perhaps as low as
$1,000 per genome, will be available in a few years, cross-
species primers may still be useful for studies in which
only a sample of a genome is needed and for which off-
the-shelf reagents are found to be convenient to obtain
the sample [2]. The results concerning the most influen-
tial factors in cross-species primer design should also be of
use in designing primers pairs for studies on other major
branches in the tree of life.
Results
Summary information on primer pairs
The summary statistics of the cross-species primers are
reported in Table 1. The total intronic region that would
be theoretically PCR-amplified in the human genome by
these primer pairs is 1,100,272 bp, and the coding region
covered is 143,282 bp (excluding the primer binding
regions). Seventeen pairs (noted in Table S1 [Additional
file 1]) have not been tested in any species, but were
designed in the same way as all of the other primer pairs
and provide additional coverage for some regions of the
genome. Products were inferred to be the intended target
if they were at least 70% identical to the intended target
and had splice signals in the same position as the human
gene. Several hundred of these products were as BLASTed
against the nonredundant Genbank database (prior to the
release of the canine genome sequence) and in all cases
the most significant sequence match was either an index
species sequence used to design the primers or an
ortholog of that sequence from another species. Of the
1147 primer pairs reported (58 previously reported [4]),
1016 were tested on dog genomic DNA and 637 (62.7%)
produced products that were shown to be the intended
target by sequence analysis (Table S1 [Additional file 1]).
If the 81 primer pairs for which dog was an index speciesBMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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are excluded, the success rate was 64.0% (598/935). An
additional 3% produced sequences that did not match the
intended target. For the hamster, 1087 primer pairs were
tested under a single reaction condition in microtiter
plates. The hamster products were not sequenced, but
based upon subject rankings derived from the experience
with the canine products, 510 (46.9%) resulted in ampli-
fications with a subjective ranking of 2, 3, or 4 that were
judged to be likely to contain the correct product (see Fig.
1 for an explanation of the ranking system and Table S1
[Additional file 1] for individual rankings). For a ranking
of 2 in which an extra band is seen, more than 95% of the
correct canine bands are closer to the human size than the
artifactual band (data not shown). Less than 11% of the
hamster amplifications deemed to be successful amplifi-
cations have a ranking of 2 (Table S1 [Additional file 1]).
Empirical determination of the impact of index-species 
mismatches on the percentage of successful amplifications
Two types of nucleotide mismatches are of interest in this
work. The first type of mismatch is that found between the
sequences of the two index species in the target region to
which a primer is designed (as noted in methods and
materials, the primer itself always exactly matches one of
the index species). These mismatches are designated as
index-species (IS) mismatches. When an IS-mismatch is
allowed, the primer is designed under the assumption
that the sequence of one the index species (the primary
index species; usually human) represents the nucleotide
in the common ancestor. The second type of mismatch is
the primer-template (PT) mismatch, in which a nucle-
otide difference is known to exist between a given primer
and a given (sequenced) target DNA.
At the beginning of this work, some primer pairs were
designed that allowed one or more IS-mismatches in
order to save labor during the primer design step. It was
known from previous results that IS-mismatched primers
often worked [12]. However, after 245 primer pairs had
been developed (for genes found on human chromo-
somes [HSA] 1, 2, 11, 17, 19, and 22), the data was ana-
lyzed to determine the impact of IS-mismatches on the
percent of primer pairs that would amplify the correct
canine gene (the canine genome sequence was not availa-
ble at the beginning of this work, and so PT-mismatches
for the dog could not be identified at that time). For this
sample it was found that 60% (66/110) of the primer
pairs amplified dog DNA if no IS-mismatches were
present in either of the forward and reverse primers, but
that only 47% (61/131) amplified if at least one IS-mis-
match was present. This result suggested that IS-mis-
matches have an important impact on amplification
success, so greater effort was made to make as many
primer pairs exactly match the two index species as possi-
ble. Analysis of the 1016 primers designed without the
dog as an index species indicated that there was a signifi-
cant difference (p = 0.00055) between the amplification
efficiency of primer pairs with no IS-mismatches (548/
841, 65.2%) vs. primers pairs with one or more IS-mis-
matches (90/175, 51.4%) (Table 2). For the 1087 primer
pairs tested with hamster DNA, amplified products (2, 3,
or 4 ranking in which it was subjectively judged that the
correct product amplified; see Fig. 1) were obtained for
Table 1: Primer and target statistics
Parameter valuea
number of primer pairs 1147
number with no IS-mismatches 955
spacing in human genome 2.3 +/- 2.4 Mb (0.0 – 23.2)
product sizeb 1130 +/- 514 bp (197 – 3862)
primer length 21.8 +/- 3.1 b (16 – 38)
annealing temperature 61.0 +/- 1.4°C (55.0 – 69.0)
introns crossed 1.08 +/- 0.36 (0 – 4)
aFor values that vary, data are given as average +/- standard deviation 
or range.
bThese values are based upon the human target.
Examples of PCR results ascribed to subjective rankings used  for cross-species amplifications shown in Table 3 Figure 1
Examples of PCR results ascribed to subjective rankings used 
for cross-species amplifications shown in Table 3. Lane num-
bers and subjective rankings appear above and below the pic-
ture, respectively. Lane 1, 100 bp ladder (Invitrogen Corp.); 
lanes 2 and 3, "4" ranking (lane 2, MACF1 monkey; lane 3, 
MACF1 dog); lanes 4 and 5, "3" ranking (lane 4, GNB1 mouse; 
lane 5, ORC4L cat); lanes 6 and 7, "2" ranking (lane 6, DVL1 
goat; lane 7, CDC7 hamster); lanes 8 and 9, "1" ranking (lane 
8, DVL1 monkey; lane 9, DVL1 pig). Ranking numbers are also 
provided below each lane. A ranking of "0" signifies that no 
bands of any kind were seen (not shown).BMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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443/905 (49.0%) of those primers with no IS-mis-
matches, but only 67/182 (36.8%) of those with one or
more mismatches (p = 0.004; Table 2). Regression analy-
sis of percent of targets successfully amplified vs. number
of IS-mismatches suggested a decrease of 6–8% in the suc-
cess rate with each additional IS-mismatch.
Subdividing the IS-mismatch primers into sets with differ-
ent numbers of IS-mismatches (1, 2, or 3) or by distribu-
tion of mismatches (e.g., one IS-mismatch in each of the
forward and reverse primers of a set, vs. two IS-mis-
matches in the forward, but none in the reverse) did not
show a statistically significant difference in success rate.
The lack of a difference could be because the sample sizes
were small for primer pairs with one or more IS-mis-
match.
Effect of primer-template mismatches on amplification 
success
The release of the assembled canine whole genome
sequence provided an opportunity to assess the impact of
the number of PT-mismatches on the success of target
amplification. Twenty primer pairs that amplified the cor-
rect dog target and 20 primer pairs that produced no prod-
uct under the standard conditions were aligned with the
homologous canine sequence (Tables S2 and S3 [Addi-
tional file 2]). For the 20 that did amplify, all but one had
two or fewer PT-mismatches. For the 20 that did not pro-
duce a dog product, all but seven had 3 or more total PT-
mismatches between the primers and the dog target.
When the sequences for the three genes that had only zero
or one mismatch but did not amplify were examined
more carefully, it was noted that they contained all or part
of a GC-rich island. All 40 genes were tested again in the
presence of 1 M betaine (a known enhancer for amplifica-
tion of GC-rich sequences), and the three high GC-con-
tent genes with zero or one mismatches produced a
product, although none of the primer pairs with three or
more PT-mismatches produced a band. These results with
the canine PT-mismatches suggest that a relatively sharp
cutoff in amplification success occurs around two to three
total PT-mismatches per primer pair under the standard
PCR conditions and for primers averaging 22 bases in
length (Table 1).
The effect of the other factors examined
In order to determine the impact of the other factors
examined on the rate of amplification success, a sample of
50 primer sets were examined across five mammalian
Orders (primates; humans and macaques: carnivores;
dogs and cats: perissodactyls; horse: artiodactyls; cows,
goats, and pigs: and rodents: hamsters, rats, and mice
(Table 3) and, in certain instances as described below,
across the complete set of primers as tested using only dog
and hamster DNA.
Among the sample of 50 primer sets tested with the two
index species' DNA (100 tests), it was unexpectedly
observed in 14 tests that the DNA from the index species
(known to have no PT-mismatches) failed to amplify or
amplified poorly (i.e., had a ranking less than 3; Table 3).
In nearly all cases, it appears that this was either due to the
presence of a processed pseudogene (as inferred by the
presence of a band that closely matched the size predicted
for the cDNA [given in Table S1 {Additional file 1} for
each target]) that served as significant competition for
amplification of the intended target, or because the region
amplified was GC-rich or contained a patch of at least 130
bp that was GC-rich (>59% G + C - often part of a GC-rich
island). A correspondingly lower overall success rate was
generally observed across the full set of species for which
one of the index species was found to have a GC-rich tem-
plate (e.g., BIN1 and DVL, found in the lower half of Table
3).
When the full set of 841 zero IS-mismatch primer pairs
was analyzed for the dog, 74.2% of targets with a human
GC content of <50% amplified, whereas only 56.9% of
targets with a GC content of ≥ 50% amplified (p = 1.9 ×
10-7) (Table 4). However, when the same analysis was
done for the hamster, no significant difference was
detected between the two groups of targets (p = 0.64). In
Table 2: Number of IS-mismatches vs. target amplification
Dog Hamster
IS-Mismatches Testeda Productb % Tested Productb %
0 841 548 65.2 905 443 49.0
1 100 55 55.0 104 44 42.3
24 3 1 9 4 4 . 2 4 4 1 6 3 6 . 4
3 25 13 62.0 26 5 19.2
4  +  5 7 34 2 . 98 22 5 . 0
aThese numbers do not include primer pairs for which the dog is an index species.
bDog products were all confirmed by sequence analysis. Hamster products were inferred to be correct based upon a subjective ranking of 2, 3, and 
4 (see Fig. 1 for ranking system).BMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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Table 3: Cross-species amplification results for 50 primer pairs with no IS-mismatches
Gene Huma Mon Dog Cat Hor Cow Goa Pig Ham Rat Mou prot idb GCc Notesd
PTBP2 4e 44 4 444 4 4 4 4 99 32.8c
HAT1 4 44 4 444 4 4 4 4 93 39.6
PTPRU 4 44 4 444 4 4 4 4 95 54.8
MACF1 4 44 4 444 4 4 4 47 8 3 7 . 8
FRAP1 4 44 4 444 4 4 4 49 9 3 9 . 9
LRP1B 4 43 4 344 4 4 4 4 91 39.5
LYST 4 44 3 34 4 4440 8 4 2 8 . 6
HNRPU 4 44 2 444 4 4 4 49 4 3 9 . 6
SLC20A1 4 44 2 444 4 4 4 4 90 39.4
RND3 4 4 0 4 4 4 4 4 4 4 4 100 51.6
CDC7 4 24 4 444 4 2 4 08 1 3 3 . 6
PABPC4 4 44 4 444 4 3 2 2 95 51.2
NR4A2 4 44 3 044 4 4 4 49 9 4 3 . 9
KYNU 3 44 3 444 0 4 4 48 5 3 0 . 5
DDX18 4 40 3 444 4 4 4 4 85 39.4
CLCN6 4 4 444 0 4 3344 9 6 5 2 . 7 1 d
PSCDBP 4 43 4 404 3 4 4 4 81 37.4
ABCA4 4 42 4 44 4 2323 8 8 5 3 . 5
MDH1 4 44 4 442 2 424 9 6 3 9 . 5
ADD2 4 40 4 442 4 2 4 4 94 51.9
CTNNA2 4 44 4 400 4 3 4 4 98 45.6
SLC1A4 4 44 4 224 2 2 3 4 89 51.8
LAMC1 4 44 4 044 0 4 2 4 92 37.9
FASLG 4 44 2 444 4 000 7 7 4 0 . 1
HK2 2 44 4 303 0 4 4 4 94 46.5 2
ORC4L 3 33 4 333 0 3 4 38 8 3 3 . 2
CCT7 2 42 2 144 4 2 2 4 95 46.2 2
FLVCR 4 4 444 0 4 1040 7 7 3 9 . 0 1
ITGAV 4 40 4 44 4 4000 9 1 3 6 . 4
MYO1B 4 44 4 000 4 4 4 4 89 31.5
RGS16 4 41 4 34 4 4000 8 4 4 4 . 7
PINK1 4 40 2 431 1 4 4 48 1 4 8 . 9
EIF5B 4 4 443 0 0 4314 7 5 3 8 . 7 1
GNB1 3 4 4 4 4 0 3 0 3 0 3 100 51.6
GDAP2 4 43 4 000 3 4 4 4 94 35.0
BIN1 0 33 3 033 3 0 3 3 69 60.8 3
WDR8 4 44 4 000 0 4 4 4 89 35.0
AP4B1 4 44 0 400 0 3 4 4 90 39.0
CYP2J2 4 4 143 3 0 2020 7 6 4 3 . 7 1
GABRD 0 12 2 122 0 4 4 49 1 6 4 . 03
SULT1C1 4 4 444 0 0 0020 8 3 4 5 . 9 1
RBBP4 2 22 2 222 0 2 2 2 99 38.8 2
DVL 0 04 2 222 0 2 2 4 95 69.6 3
SAC 4 00 4 400 0 4 4 37 3 4 5 . 0
CCNT2 0 00 4 000 4 4 4 4 69 54.6 3
JAK1 4 00 4 003 4 404 9 3 5 2 . 4
TBR1 0 30 2 011 2 3 3 3 99 53.4 3
WDR39 1 00 2 101 0 3 4 4 94 54.1 3
ARID4B 1 30 0 000 0 3 3 18 7 3 5 . 73
STAT1 0 30 0 000 0 0 4 49 2 3 9 . 94
aBoxes indicate index species used to design primers. Species abbreviations are: Hum, human; Mon, monkey; Hor, horse; Goa, goat; Ham, hamster; 
Mou, mouse.
aThese numbers are the percent protein sequence identity between human and mouse.
cThese numbers are the G + C content in the e-PCR amplified human product.
dNotes: 1, rabbit was the second index species for these primer pairs, except FLVCR, for which cat was used; 2, one or more processed 
pseudogenes apparent in the human genome; 3, contains a > 130 bp window in amplified human product with > 59% G + C; 4, strong primer-dimer 
seen in amplifications.
eNumbers 0–4 correspond to amplification rankings as exemplified in Fig. 1.BMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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order to provide evidence that this might be due to GC
content differences between the homologous targets of
the dog and hamster, the GC content was determined for
the 30 targets with zero IS-mismatches between human
and mouse (a rodent for which sequence is available) for
which the human target had a GC content ≥60%. The
result was that the mouse target had, on average, 6.9% less
G+Cs than the human target.
Because of the impact of human GC-content on the
amplification efficiency for some primer pairs for some
species, we made an empirical assessment of the impact of
including 1 M betaine on the percent of successful ampli-
fications compared to the standard conditions using a
non-rodent, non-primate species. Primer pairs for 87
genes on HSA6 were used to amplify pig DNA in a micro-
titer-plate format. Under standard conditions, 39 pairs
produced a band of the expected size (34 as single bands
that should be amenable to direct sequence analysis).
Bands appeared for twelve additional genes when 1 M
betaine was included (all single bands in this experi-
ment). However, the bands for 6 other pairs (all single
bands) that were present under the standard conditions
disappeared with the inclusion of betaine (data not
shown).
Several other parameters were examined for a possible
effect upon amplification efficiency by examining the
results obtained with the sample of 50 primer pairs
among the species from five mammalian Orders. The
parameters included primer length, sequence identity
between the human and mouse proteins encoded by each
gene, and CpG-content of the primer region. No signifi-
cant effect of primer length on amplification success was
observed. A modest, but statistically significant, effect (R2
= 0.14, p = 0.016) was observed for sequence identity on
proportion of species amplified. The effect of CpGs on
amplification success was examined because it is known
that CpGs are, in general, hotspots for mutation depend-
ing upon their methylation status and might therefore be
expected to cause a greater number of PT-mismatches for
primers that overlie CpGs [15]. However, no statistically
significant effect on amplification success was found for
CpG content within the sample of 50 primer pairs used
with the DNA from the 11 species. The effect of CpGs in
the primer region was also examined in the complete data
sets for the dog and hamster DNA and again no statisti-
cally significant association was found.
It was also observed that there tended to be a higher suc-
cess rate for species within the same Order as one of the
index species as compared to species in Orders other than
those of the index species, as would be expected and as
previously shown for randomly designed primers [6]. For
example, for the 24 primer pairs for which the mouse was
an index species, 24 of the rat and 23 of the hamster tar-
gets amplified, but only 14 of the cow, 14 of the goat, and
16 of the pig targets amplified (p ≤ 0.01 for within- vs.
between-Order amplification).
Discussion
The goals of this work were to determine what factors
influence the success rate for cross-species primers and to
develop a set of cross-species primers that would cover
most of any mammalian genome and that could be used
under a single standard reaction condition with a predict-
able rate of success. Of the 1147 primer pairs designed,
955 (83.3%) have zero IS-mismatches. Of those tested in
the dog, 65.2% of the targets were amplified and verified
to be the correct target by sequence analysis (Table 2).
These were amplified under a single amplification condi-
tion, suggesting that the primer pairs should be useful for
high throughput data collection for un-sequenced mam-
malian genomes. Although 16.7% of the 1147 primer
pairs have one or more IS-mismatches, they still produce
correctly amplified products in about 36.5% of hamster
targets and 49% of the canine targets. The single condition
Table 4: PCR success vs. target GC content for zero IS-mismatch primer pairs
dog hamster
GC range no. tested successful PCR % no. tested successful PCRa %
24–30 31 26 83.9 33 16 48.5
30–35 167 129 77.2 189 83 43.9
35–40 186 131 70.4 195 91 46.7
40–45 148 109 73.6 160 81 50.6
45–50 91 58 63.7 101 50 49.5
50–55 99 67 67.7 103 54 52.4
55–60 69 34 49.3 70 30 42.9
60–65 37 13 35.1 42 22 52.4
>65 10 2 20.0 12 4 33.3
aSuccessful hamster amplifications are based upon subjective rankings of 2, 3, and 4 (see Fig. 1 for the ranking system).BMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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that we used was chosen because it has generally worked
well in our lab for cross-species primer work.
Before examining the importance of the design factors
studied, it may be helpful to briefly discuss the rationale
we used to design these primer pairs. When the sequences
for two index species are aligned, we assume that identical
nucleotides have not changed from the common ancestral
sequence. Once an ancestral sequence has been inferred,
the rate of evolution from the ancestor to the target species
(i.e., the number of substitutions that are fixed in the
primer binding regions) is then a major determining fac-
tor of amplification success. As a corollary, if a stretch of
sequence is identical, it is only necessary to align two
index species sequences to infer the sequence of the com-
mon ancestor. Incorrect inference occurs in the case of
parallel substitutions (or other types of molecular evolu-
tion that lead to homoplasy) when using sequences of
only two index species [16]. The sequences of five diver-
gent species are required to be able to recognize most
cases of parallel substitution and, because parallel substi-
tutions are relatively rare, the gain from the additional
work to obtain multi-species alignments would only mar-
ginally increase the success rate of cross-species primers.
With regard to the other factors examined, no statistically
significant correlation was found between amplification
success and the length of primers (between 18 and 30
bases), and with the number of CpG dinucleotides con-
tained in the primers. A statistically significant effect was
found with the degree of sequence identity between the
proteins of human and mouse. However, the predictive
value (R2 = 0.14) is relatively modest, and it may not be
worth the effort to use this factor for the selection of gene
targets.
The impact of GC-richness in a target is a significant deter-
minant of amplification efficiency for the dog, and prob-
ably other species with the common mammalian GC
content pattern, at least under the standard conditions
used in this work. However, it may be difficult to avoid
using these targets if samples for all segments of a mam-
malian genome are desired as, for example, when devel-
oping markers for whole genome linkage scans. This is
because large stretches (isochores) of most mammalian
genomes tend to be GC-rich and it may not be possible to
find a conserved region that does not reflect this GC-rich
condition. There also tends to be a correlation between
high gene density and GC-richness in mammalian
genomes, and it will generally be necessary to identify pol-
ymorphisms in these regions [17,18]. Use of a reaction
condition that increases the amplification efficiency of
GC-rich targets, such as the inclusion of 1 M betaine, can
be used for regions where this problem is encountered. By
using this one additional reaction condition, an estimated
5–10% of additional targets will amplify; however, a
roughly equivalent number of bands compared to the
standard condition may be lost, so it is best not to use the
betaine condition by itself. Other reaction conditions
(e.g., different cycling conditions, reactant concentra-
tions) were not examined systematically or in any detail in
this work.
In contrast to the canine genome, there is a lack of an asso-
ciation for the hamster between the human GC content of
a target and the amplification success rate. One explana-
tion for this striking contrast may be that the hamster
genome, like the mouse genome, has significantly less
GC-rich regions (i.e., those over 50% G+C) than the
human and most other non-rodent genomes. This "murid
shift" in GC content appears to be specific to rodents in
contrast to the general mammalian pattern [19,20]. We
verified that the mouse targets for the most GC-rich
human genes are much less GC-rich by an average of 6.9%
(e.g., a human target that is 60% GC would only be 53%
GC in the mouse). At least one report in which two partic-
ular genes of rodents were studied provides data suggest-
ing that the GC-content of hamster DNA may be 3% lower
than that of the mouse, and this is in keeping with the lack
of a significant effect of human GC content as a predictor
of hamster PCR success rate [21]. Further work will be
needed to directly verify the lower GC content in the ham-
ster targets. We cannot explain the overall lower success
rate of the hamster targets as compared to the canine tar-
gets, although perhaps our microtiter plate format is
somewhat less efficient than our single tube format. Fur-
ther work will also be needed to explain this difference.
As one would certainly expect, PT-mismatches and IS-mis-
matches (as predictors of PT-mismatches) are important
determinants of the probability that a target will amplify.
The data reported here provide: (1) an estimate of the
number of PT-mismatches that will still allow amplifica-
tion to occur (generally no more than 2 under the condi-
tions reported) and (2) an estimate of the impact of IS-
mismatches on the probability of amplification success
(e.g., a decrease in success rate for hamster DNA from
49.0% for no IS-mismatches to 19.2% for three IS-mis-
matches). Under the standard conditions used here, we
observed that if two or fewer primer-binding region sub-
stitutions occur during the evolutionary period from the
common ancestor to the target species, amplification is
likely, and if three or more substitutions occur, amplifica-
tion is unlikely. We have observed cases where three or
more PT-mismatches will still allow amplification, but
these are relatively rare (e.g., NUP53 in Table S2 [Addi-
tional file 2], and Housley and Venta, unpublished obser-
vations). The data presented here were not sufficient to
determine of what importance the distribution of PT-mis-BMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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matches within the forward and reverse primers might
have on amplification efficiency.
Based upon the simplifying assumptions that mutations
occur randomly, that non-synonymous changes do not
occur in conserved regions, and that the fixation of synon-
ymous mutations follows a Poisson distribution, the pro-
portion of primer binding regions that will have three or
more mismatches can be calculated based upon the rate of
evolution for the gene in question between the two index
species. Despite the obvious oversimplification, a prelim-
inary analysis suggests an approximate fit between the
predicted and observed data. A broader implication for
this simple model is that it should be possible to select
index species based upon the rate of divergence in coding
regions for any group of organisms (e.g., plants, animals,
microorganisms) that will provide a predictable rate of
success prior to designing primers. Degree of divergence
between representative genomes of a clade (say perhaps
chicken and zebra finch for birds) might therefore be
included among the criteria for selecting which genomes
to sequence next.
Although it is probably possible to obtain a marginal
increase in the proportion of amplified products that can
be obtained by using multiple reaction conditions, we
suggest that it may be more efficient to use a single condi-
tion, such as the one reported here, to maximize the
amount of data obtained for a given amount of effort and
time. If a somewhat higher success rate is desired, we sug-
gest that one additional condition be used, that being the
inclusion of an enhancer such as betaine for GC-rich tar-
gets. If the whole set of 1147 primer pairs is not needed,
then the primer pairs contained in Table S1 [Additional
file 1] can be sorted to select a desired combination of
properties (e.g., only pairs with no IS-mismatches, GC-
content below 50%, greatest amount of coding region
obtained, etc.).
There are several areas of research in which cross-species
primers have been of value. For example, they have been
used for the construction of physical maps of genomes by
radiation hybrid (RH) mapping and/or genetic maps by
identifying genetic variation in the amplified products
[4,22,23]. Construction of these maps by using these
primers might be particularly useful for studies of chro-
mosomal evolution [24]. The amplification information
provided here on the hamster targets may help in the
selection of primer pairs for radiation hybrid mapping
because hamster cells are most often used as the recipient
for RH work [4,22,25]. Some researchers prefer primer
pairs that do not amplify the potentially interfering ham-
ster band (and may even develop new species-specific
primers after determining the sequence of the amplified
product), while others prefer to have presence of the ham-
ster band as an internal amplification control [26,27].
Cross-species primers have also been used successfully for
other purposes, such as the study of the molecular evolu-
tion of organisms [11,28,29]. Indeed, it has been sug-
gested that the sequences of nuclear genes may provide
more accurate information for studies of evolution and
conservation compared to the more heavily used
sequences of mitochondrial DNA [30].
The choice between whole genome sequencing, EST
sequencing, or use of cross-species primers will depend
upon the goals and resources available for each research
project. Cross-species primers will remain cost-effective
for projects involving comparison of multiple species
because a single set of primers can be utilized to amplify
across many related genomes, without the need to design
and synthesize individual primer pairs for each different
species. However, once the methods for producing the
sequence of a complex genome for $1,000 have been real-
ized, the value of cross-species primers will be greatly
diminished in instances where a single species is of inter-
est, because it will be possible to obtain complete genome
sequence information at a low cost [31]. Until this has
been accomplished, however, cross-species primers may
be of use for obtaining data that will lead to insights in
evolution, genomics, and possibly other areas of biology.
Conclusion
The relatively recent completion of the canine genome
sequence allowed us to identify several factors that have a
significant impact on the efficiency of cross-species prim-
ers for use in a high throughput fashion. These include the
number of index-species mismatches, the GC-content of
the target amplimer, and the degree to which a target spe-
cies is related to one of the index species. On the other
hand, the presence of CpG dinucleotides (with their rela-
tively high genome-wide mutation rates), the length of
the primers within the range studied (18 – 30mers), and
the degree of encoded protein sequence conservation
appear to have a minimal impact on the probability that
a given primer set will amplify a given target. These obser-
vations should aid in developing automated systems for
cross-species primer design for clades of life (e.g., non-
mammalian vertebrates species such as birds, insect spe-
cies such as mosquitoes, and plant species such as Orders
of dicots) in which only a few model organism genomes
have been sequenced. In addition, the 1147 primer sets
used in the study may have immediate uses in genetics
and genomics of mammalian species in which whole
genome sequences are not yet available.
Methods
Selection of gene targets and DNA samples
Genes were selected to give reasonably even coverage
across the entire human genome by use of the UCSCBMC Genomics 2006, 7:253 http://www.biomedcentral.com/1471-2164/7/253
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Genome Browser [32]. With a few exceptions, targets were
chosen that had an intron size of a few hundred to 2000
bp. An attempt was made to avoid genes that tend to pro-
duce multiple pseudogenes (e.g., genes encoding ribos-
omal proteins; [33]). Genomic DNA samples isolated
from blood, tissue, or cell culture were obtained for 11
species (human, pigtail macaque, dog, cat, horse, goat,
cow, pig, Chinese hamster, rat, and mouse) representing
five mammalian Orders. Other researchers provided most
of these; however, the hamster DNA was isolated by a
standard phenol-chloroform extraction method from a
CHO cell line.
Design of primers
Primers were manually designed to conserved regions
between two species (the index species) of different mam-
malian orders (generally human and either rat or mouse).
The 3' end of the forward primer was generally designed
to overlie a second codon position and the 3' end of the
reverse primer was generally designed to overlie the first
codon position. Except in 6 cases, the forward and reverse
primer had annealing temperatures within 4°C of one
another. Eighty-four percent of the primers pairs were
designed to completely conserved regions.
Occasionally IS-mismatches (defined in the Results sec-
tion) were allowed in the primer-binding region, gener-
ally when no completely conserved region could be
found. In most of these cases, the primer was designed to
exactly match the human gene sequence because it is
thought that primate molecular evolution is significantly
slower than rodent evolution and the human should,
therefore, be more likely to match the sequence of the
common ancestor to primates and rodents [34]. Occa-
sionally, dog was used as the second index species and
primers were designed to exactly match the dog, because
this species is of major interest in our lab. Predicted prod-
uct sizes for the human targets were determined by using
the in-silico PCR (ePCR) function of the UCSC Genome
Browser [32]. The primer sequences, predicted product
sizes from the human genome, melting temperatures,
presence of amplified products from the hamster genome,
and other pertinent data are contained in Table S1 [Addi-
tional file 1].
PCR conditions
Targets were amplified from 10 to 50 ng of genomic DNA
in a 25 µl volume containing 10 mM Tris (pH 8.3 at
20°C), 50 mM KCl, 100 µM dNTPs, 1.5 mM MgCl2, 0.08
µM of each primer, and 0.5 U Taq DNA polymerase (Inv-
itrogen Corp., Carlsbad, CA). The PCRs for the dog targets
were cycled in a MJR-100 Thermocycler for 1 min at 94°C,
2 min at 59°C, and 3 min at 72°C for 35 cycles. Fifty
primer sets were tested for amplification across species
using the identical single condition given for the dog
amplifications. The hamster and pig DNA samples were
also amplified under the same conditions, but in a micro-
titer plate format using a Robocycler (Stratagene, Corp.,
La Jolla, CA). In a limited number of cases where GC-rich
targets were known or expected, 1 M betaine was added to
the standard reaction [35]. These cases are specifically
noted in the Results.
Gel electrophoresis and sequence analysis
Dog amplification products were run on 2% agarose gels
with standard gel electrophoresis units and stained with
ethidium bromide to visualize bands. Hamster products
underwent electrophoresis using a rapid agarose gel elec-
trophoresis (RAGE) unit (Cascade Biologics, Inc., Port-
land, OR). PCR products were generally gel-purified using
the Qiaex II gel extraction kit (Qiagen Corp., Valencia,
CA), but some automated sequencing was performed
directly from the amplification reactions. Manual
sequencing was performed using the Thermo Sequenase
Radiolabeled Terminator Cycle Sequencing Kit (USB
Corp., Cleveland, OH). The identity of the sequence was
confirmed by BLAST analysis [36] or, later, by BLAT anal-
ysis [32] when this program became available [37, 38].
Canine sequences were inferred to be homologous to the
intended target if the most significant match identified
using BLAST or BLAT was the correct gene or mRNA in any
mammalian species and if the splice point(s) were in the
expected position relative to the coding region.
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